Prodromal features for Parkinson's disease - baseline data from the TREND study

European Journal of Neurology

Volumn 21, Issue 5, 2014, Pages 766-772

  Gaenslen, A ^a,b   Wurster, I ^a,b   Brockmann, K ^a,b   Huber, H ^a,b   Godau, J ^a,b   Faust, B ^a,b   Lerche, S ^a,b   Eschweiler, G W ^c   Maetzler, W ^a,b   Berg, D ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Parkinson's disease; Prodromal phase; Risk markers

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PROSPECTIVE STUDY; QUESTIONNAIRE; REM SLEEP; RISK FACTOR; TREND STUDY; UNITED KINGDOM; AGE; COHORT ANALYSIS; COMPLICATION; DEGENERATIVE DISEASE; DISEASE COURSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; REM SLEEP BEHAVIOR DISORDER; RETROSPECTIVE STUDY; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DEPRESSION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PRODROMAL SYMPTOMS; REM SLEEP BEHAVIOR DISORDER; RETROSPECTIVE STUDIES;

EID: 84897957919     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12382     Document Type: Article

References (27)

1. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114(Pt 5): 2283-2301.
2. Postuma RB, Gagnon JF, Montplaisir J. Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry 2010; 81: 1008-1013.
3. Maetzler W, Hausdorff JM. Motor signs in the prodromal phase of Parkinson's disease. Mov Disord 2012; 27: 627-633.
4. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003; 18: 467-486.
5. Siderowf A, Jennings D, Eberly S, et al. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study. Mov Disord 2012; 27: 406-412.
6. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009; 72: 1296-1300.
7. Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 2006; 113: 211-220.
8. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57: 456-462.
9. Muller B, Larsen JP, Wentzel-Larsen T, Skeie GO, Tysnes OB. Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord 2010; 26: 65-72.
10. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 2008; 72: 1121-1126.
11. Stamey W, Davidson A, Jankovic J. Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol 2008; 14: 253-254.
12. Diederich NJ, Pieri V, Hipp G, Rufra O, Blyth S, Vaillant M. Discriminative power of different nonmotor signs in early Parkinson's disease. A case-control study. Mov Disord 2010; 25: 882-887.
13. Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR. Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. Parkinsonism Relat Disord 2011; 18(Suppl. 1): S199-S202.
14. Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D. The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease. Mov Disord 2011; 26: 653-658.
15. Berg D, Seppi K, Behnke S, et al. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 2011; 68: 932-937.
16. Liepelt-Scarfone I, Behnke S, Godau J, et al. Relation of risk factors and putative premotor markers for Parkinson's disease. J Neural Transm 2011; 118: 579-585.
17. Berg D. Is pre-motor diagnosis possible? The European experience. Parkinsonism Relat Disord 2012; 18(Suppl. 1): S195-S198.
18. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-2170.
19. Hobert MA, Niebler R, Meyer SI, et al. Poor trail making test performance is directly associated with altered dual task prioritization in the elderly - baseline results from the TREND study. PLoS One 2011; 6: e27831.
20. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatry Association, 1994.
21. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997; 22: 39-52.
22. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire - a new diagnostic instrument. Mov Disord 2007; 22: 2386-2393.
23. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
24. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA 2002; 288: 2307-2312.
25. Liepelt I, Behnke S, Schweitzer K, et al. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population. Neurobiol Aging 2011; 32: 1599-1606.
26. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Subjective complaints precede Parkinson disease: the Rotterdam study. Arch Neurol 2006; 63: 362-365.
27. Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB. Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease. Mov Disord 2007; 22: 2249-2255.